Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish

Inflammatory Bowel Diseases

Volumn 20, Issue 5, 2014, Pages 956-966

  Yang, Ye ^a   Tomkovich, Sarah ^a,b   Jobin, Christian ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Homeostasis; Host microbe interactions; Intestinal epithelial cell; Intestine; Microbiota

Indexed keywords

ADAPTIVE IMMUNITY; ENTEROCOLITIS; ENTEROPATHY; EOSINOPHIL; GENETIC MODEL; HOMEOSTASIS; HOST; IMMUNE RESPONSE; IMMUNOLOGY; IMMUNOPATHOLOGY; INTESTINAL IMMUNE DISORDER; INTESTINE; INTESTINE FLORA; MICROBIAL COMMUNITY; MICROFLORA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; ZEBRA FISH; ANIMAL; DISEASE MODEL; HOST PATHOGEN INTERACTION; MOUSE; PATHOPHYSIOLOGY; RAT;

ANIMALS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; INTESTINAL DISEASES; MICE; RATS; ZEBRAFISH;

EID: 84902121990     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000442923.85569.68     Document Type: Review

References (134)

1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54 e42; quiz e30.
2. Prideaux L, Kamm MA, De Cruz PP, et al. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27:1266-1280.
3. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 2013;145:158-165 e152.
4. Levi Z, Shamiss A, Fraser GM, et al. The increasing prevalence of inflammatory bowel diseases among Jewish adolescents and the sociodemographic factors associated with diagnosis. In flamm Bowel Dis. 2013;19:1867-1871.
5. Chuang CH, Lin SH, Chen CY, et al. Increasing incidence and Lifetime risk of inflammatory bowel disease in Taiwan: a Nationwide study in a low-endemic area 1998-2010. In flamm Bowel Dis. 2013;19:2815-2819.
6. Wang XQ, Zhang Y, Xu CD, et al. Inflammatory bowel disease in Chinese children: a multicenter analysis over a decade from Shanghai. In flamm Bowel Dis. 2013;19:423-428.
7. Al-Mofarreh MA, Al-Mofleh IA. Emerging inflammatory bowel disease in saudi outpatients: a report of 693 cases. Saudi J Gastroenterol. 2013; 19:16-22.
8. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008;8:458-466.
9. Bakhtiar SM, LeBlanc JG, Salvucci E, et al. Implications of the human microbiome in inflammatory bowel diseases. FEMS Microbiol Lett. 2013;342:10-17.
10. Berry D, Reinisch W. Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases? Best Pract Res Clin Gastroenterol. 2013;27:47-58.
11. De Cruz P, Prideaux L, Wagner J, et al. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. In flamm Bowel Dis. 2012;18:372-390.
12. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119-124.
13. Ananthakrishnan AN. Environmental triggers for inflammatory bowel disease. Curr Gastroenterol Rep. 2013;15:302.
14. Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 2013;144:36-49.
15. Yamamoto T. Nutrition and diet in inflammatory bowel disease. Curr Opin Gastroenterol. 2013;29:216-221.
16. Mizoguchi A. Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci. 2012;105:263-320.
17. Kanther M, Rawls JF. Host-microbe interactions in the developing zebrafish. Curr Opin Immunol. 2010;22:10-19.
18. Meijer AH, Spaink HP. Host-pathogen interactions made transparent with the zebrafish model. Curr Drug Targets. 2011;12:1000-1017.
19. Goldsmith JR, Jobin C. Think small: zebrafish as a model system of human pathology. J Biomed Biotechnol. 2012;2012:817341.
20. White RM, Sessa A, Burke C, et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell. 2008;2:183-189.
21. Huang P, Zhu Z, Lin S, et al. Reverse genetic approaches in zebrafish. J Genet Genomics. 2012;39:421-433.
22. Lawson ND, Wolfe SA. Forward and reverse genetic approaches for the analysis of vertebrate development in the zebrafish. Dev Cell. 2011;21: 48-64.
23. Lam SH, Chua HL, Gong Z, et al. Development and maturation of the immune system in zebrafish, Danio rerio: a gene expression profiling, in situ hybridization and immunological study. Dev Comp Immunol. 2004; 28:9-28.
24. Danilova N, Hohman VS, Sacher F, et al. T cells and the thymus in developing zebrafish. Dev Comp Immunol. 2004;28:755-767.
25. Ng AN, de Jong-Curtain TA, Mawdsley DJ, et al. Formation of the digestive system in zebrafish: III. Intestinal epithelium morphogenesis. Dev Biol. 2005;286:114-135.
26. Wallace KN, Akhter S, Smith EM, et al. Intestinal growth and differentiation in zebrafish. Mech Dev. 2005;122:157-173.
27. Wallace KN, Pack M. Unique and conserved aspects of gut development in zebrafish. Dev Biol. 2003;255:12-29.
28. Menke AL, Spitsbergen JM, Wolterbeek AP, et al. Normal anatomy and histology of the adult zebrafish. Toxicol Pathol. 2011;39:759-775.
29. Wang Z, Du J, Lam SH, et al. Morphological and molecular evidence for functional organization along the rostrocaudal axis of the adult zebrafish intestine. BMC Genomics. 2010;11:392.
30. Lieschke GJ, Trede NS. Fish immunology. Curr Biol. 2009;19:R678-R682.
31. Oehlers SH, Flores MV, Chen T, et al. Topographical distribution of antimicrobial genes in the zebrafish intestine. Dev Comp Immunol. 2011; 35:385-391.
32. Rawls JF, Mahowald MA, Ley RE, et al. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell. 2006;127:423-433.
33. Rawls JF, Samuel BS, Gordon JI. Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota. Proc Natl Acad Sci U S A. 2004;101:4596-4601.
34. Yan Q, van der Gast CJ, Yu Y. Bacterial community assembly and turnover within the intestines of developing zebrafish. PloS One. 2012;7: e30603.
35. Lan CC, Love DR. Molecular characterisation of bacterial community structure along the intestinal tract of zebrafish (Danio rerio): a pilot study. ISRN Microbiol. 2012;2012:590385.
36. Mukhopadhya I, Hansen R, El-Omar EM, et al. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol. 2012;9:219-230.
37. Roeselers G, Mittge EK, Stephens WZ, et al. Evidence for a core gut microbiota in the zebrafish. ISME J. 2011;5:1595-1608.
38. Semova I, Carten JD, Stombaugh J, et al. Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host Microbe. 2012;12:277-288.
39. Sullam KE, Essinger SD, Lozupone CA, et al. Environmental and ecological factors that shape the gut bacterial communities of fish: a metaanalysis. Mol Ecol. 2012;21:3363-3378.
40. Wong S, Rawls JF. Intestinal microbiota composition in fishes is influenced by host ecology and environment. Mol Ecol. 2012;21:3100-3102.
41. Bajoghli B. Evolution and function of chemokine receptors in the immune system of lower vertebrates. Eur J Immunol. 2013;43:1686-1692.
42. Ma D, Wei Y, Liu F. Regulatory mechanisms of thymus and T cell development. Dev Comp Immunol. 2013;39:91-102.
43. Meeker ND, Trede NS. Immunology and zebrafish: spawning new models of human disease. Dev Comp Immunol. 2008;32:745-757.
44. Palti Y. Toll-like receptors in bony fish: from genomics to function. Dev Comp Immunol. 2011;35:1263-1272.
45. Rauta PR, Nayak B, Das S. Immune system and immune responses in fish and their role in comparative immunity study: a model for higher organisms. Immunol Lett. 2012;148:23-33.
46. Rebl A, Goldammer T, Seyfert HM. Toll-like receptor signaling in bony fish. Vet Immunol Immunopathol. 2010;134:139-150.
47. Renshaw SA, Trede NS. A model 450 million years in the making: zebrafish and vertebrate immunity. Dis Model Mech. 2012;5:38-47.
48. van der Vaart M, Spaink HP, Meijer AH. Pathogen recognition and activation of the innate immune response in zebrafish. Adv Hematol. 2012;2012:159807.
49. Xu J, Du L, Wen Z. Myelopoiesis during zebrafish early development. J Genet Genomics. 2012;39:435-442.
50. Oehlers SH, Flores MV, Hall CJ, et al. The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved antibacterial roles in zebrafish. Dis Model Mech. 2011;4:832-841.
51. van der Vaart M, van Soest JJ, Spaink HP, et al. Functional analysis of a zebrafish myd88 mutant identifies key transcriptional components of the innate immune system. Dis Model Mech. 2013;6:841-854.
52. Kanther M, Sun X, Muhlbauer M, et al. Microbial colonization induces dynamic temporal and spatial patterns of NF-kappaB activation in the zebrafish digestive tract. Gastroenterology. 2011;141:197-207.
53. Woods IG, Kelly PD, Chu F, et al. A comparative map of the zebrafish genome. Genome Res. 2000;10:1903-1914.
54. Sepulcre MP, Alcaraz-Perez F, Lopez-Munoz A, et al. Evolution of lipopolysaccharide (LPS) recognition and signaling: fish TLR4 does not recognize LPS and negatively regulates NF-kappaB activation. J Immunol. 2009;182:1836-1845.
55. Sullivan C, Charette J, Catchen J, et al. The gene history of zebrafish tlr4a and tlr4b is predictive of their divergent functions. J Immunol. 2009;183:5896-5908.
56. Sommer F, Backhed F. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol. 2013;11:227-238.
57. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489:242-249.
58. Kamada N, Seo SU, Chen GY, et al. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013;13:321-335.
59. Bates JM, Mittge E, Kuhlman J, et al. Distinct signals from the microbiota promote different aspects of zebrafish gut differentiation. Dev Biol. 2006;297:374-386.
60. Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291:881-884.
61. Zambonino Infante JL, Cahu CL. Ontogeny of the gastrointestinal tract of marine fish larvae. Comp Biochem Physiol C Toxicol Pharmacol. 2001;130:477-487.
62. Henning SJ. Ontogeny of enzymes in the small intestine. Annu Rev Physiol. 1985;47:231-245.
63. Falk P, Roth KA, Gordon JI. Lectins are sensitive tools for defining the differentiation programs of mouse gut epithelial cell lineages. Am J Physiol. 1994;266:G987-G1003.
64. Cheesman SE, Neal JT, Mittge E, et al. Epithelial cell proliferation in the developing zebrafish intestine is regulated by the Wnt pathway and microbial signaling via Myd88. Proc Natl Acad Sci U S A. 2011;108 (suppl 1):4570-4577.
65. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229-241.
66. Gibson DL, Ma C, Bergstrom KS, et al. MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell Microbiol. 2008;10:618-631.
67. Pull SL, Doherty JM, Mills JC, et al. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci U S A. 2005; 102:99-104.
68. Hikasa H, Sokol SY. Wnt signaling in vertebrate axis specification. Cold Spring Harb Perspect Biol. 2013;5:a007955.
69. Carten JD, Bradford MK, Farber SA. Visualizing digestive organ morphology and function using differential fatty acid metabolism in live zebrafish. Dev Biol. 2011;360:276-285.
70. Walters JW, Anderson JL, Bittman R, et al. Visualization of lipid metabolism in the zebrafish intestine reveals a relationship between NPC1L1-mediated cholesterol uptake and dietary fatty acid. Chem Biol. 2012;19: 913-925.
71. Galindo-Villegas J, Garcia-Moreno D, de Oliveira S, et al. Regulation of immunity and disease resistance by commensal microbes and chromatin modifications during zebrafish development. Proc Natl Acad Sci U S A. 2012;109:E2605-E2614.
72. Bates JM, Akerlund J, Mittge E, et al. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe. 2007;2:371-382.
73. Yang Y, Wandler AM, Postlethwait JH, et al. Dynamic evolution of the LPS-detoxifying Enzyme intestinal alkaline phosphatase in zebrafish and other vertebrates. Front Immunol. 2012;3:314.
74. Carnevali O, Avella MA, Gioacchini G. Effects of probiotic administration on zebrafish development and reproduction. Gen Comp Endocrinol. 2013;188:297-302.
75. Rendueles O, Ferrieres L, Fretaud M, et al. A new zebrafish model of oro-intestinal pathogen colonization reveals a key role for adhesion in protection by probiotic bacteria. PLoS Pathog. 2012;8:e1002815.
76. Brugman S, Liu KY, Lindenbergh-Kortleve D, et al. Oxazolone-induced enterocolitis in zebrafish depends on the composition of the intestinal microbiota. Gastroenterology. 2009;137:1757-1767 e1751.
77. Hoentjen F, Harmsen HJ, Braat H, et al. Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice. Gut. 2003;52:1721-1727.
78. Kanther M, Tomkovich S, Sun X, et al. Commensal microbiota stimulate systemic neutrophil migration through induction of Serum amyloid A. Cell Microbiol. [published online ahead of print December 26, 2013]. doi: 10.1111/cmi.12257.
79. Heller F, Fuss IJ, Nieuwenhuis EE, et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity. 2002;17:629-638.
80. Boirivant M, Fuss IJ, Chu A, et al. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med. 1998;188:1929-1939.
81. Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med. 2008;263:597-606.
82. Crawford KC, Vega Flores M, Oehlers SH, et al. Zebrafish heat shock protein a4 genes in the intestinal epithelium are up-regulated during inflammation. Genesis. 2011;49:905-911.
83. Fleming A, Jankowski J, Goldsmith P. In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study. In flamm Bowel Dis. 2010;16:1162-1172.
84. Oehlers SH, Flores MV, Hall CJ, et al. Expression of zebrafish cxcl8 (interleukin-8) and its receptors during development and in response to immune stimulation. Dev Comp Immunol. 2010;34:352-359.
85. Oehlers SH, Flores MV, Okuda KS, et al. A chemical enterocolitis model in zebrafish larvae that is dependent on microbiota and responsive to pharmacological agents. Dev Dyn. 2011;240:288-298.
86. Oehlers SH, Flores MV, Hall CJ, et al. Retinoic acid suppresses intestinal mucus production and exacerbates experimental enterocolitis. Dis Model Mech. 2012;5:457-467.
87. Araki A, Kanai T, Ishikura T, et al. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol. 2005;40:16-23.
88. Miller MJ, Sadowska-Krowicka H, Chotinaruemol S, et al. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther. 1993;264:11-16.
89. Pilichos CJ, Kouerinis IA, Zografos GC, et al. The effect of nitric oxide synthases inhibitors on inflammatory bowel disease in a rat model. In Vivo. 2004;18:513-516.
90. Zlotnik A, Yoshie O, Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 2006;7:243.
91. Mizushima T. HSP-dependent protection against gastrointestinal diseases. Curr Pharm Des. 2010;16:1190-1196.
92. Nakamura K, Rokutan K, Marui N, et al. Induction of heat shock proteins and their implication in protection against ethanol-induced damage in cultured guinea pig gastric mucosal cells. Gastroenterology. 1991;101:161-166.
93. Otaka M, Odashima M, Tamaki K, et al. Expression and function of stress (heat shock) proteins in gastrointestinal tract. Int J Hyperthermia. 2009;25:634-640.
94. Oyake J, Otaka M, Matsuhashi T, et al. Over-expression of 70-kDa heat shock protein confers protection against monochloramine-induced gastric mucosal cell injury. Life Sci. 2006;79:300-305.
95. Faure M, Moennoz D, Montigon F, et al. Mucin production and composition is altered in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci. 2003;48:1366-1373.
96. Perse M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol. 2012;2012:718617.
97. Maiden L, Thjodleifsson B, Theodors A, et al. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology. 2005;128:1172-1178.
98. Morteau O, Morham SG, Sellon R, et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-J Clin Invest. 2000;105:469-478.
99. Goldsmith JR, Cocchiaro JL, Rawls JF, et al. Glafenine-induced intestinal injury in zebrafish is ameliorated by mu-opioid signaling via enhancement of Atf6-dependent cellular stress responses. Dis Model Mech. 2013;6:146-159.
100. Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol. 2013;13:722-737.
101. Goldsmith JR, Uronis JM, Jobin C. Mu opioid signaling protects against acute murine intestinal injury in a manner involving Stat3 signaling. Am J Pathol. 2011;179:673-683.
102. Stockhammer OW, Zakrzewska A, Hegedus Z, et al. Transcriptome profiling and functional analyses of the zebrafish embryonic innate immune response to Salmonella infection. J Immunol. 2009;182:5641-5653.
103. van der Sar AM, Stockhammer OW, van der Laan C, et al. MyD88 innate immune function in a zebrafish embryo infection model. Infect Immun. 2006;74:2436-2441.
104. Feng CG, Scanga CA, Collazo-Custodio CM, et al. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol. 2003;171:4758-4764.
105. Issac JM, Sarawathiamma D, Al-Ketbi MI, et al. Differential outcome of infection with attenuated Salmonella in MyD88-deficient mice is dependent on the route of administration. Immunobiology. 2013;218:52-63.
106. Ko HJ, Yang JY, Shim DH, et al. Innate immunity mediated by MyD88 signal is not essential for induction of lipopolysaccharide-specific B cell responses but is indispensable for protection against Salmonella enterica serovar Typhimurium infection. J Immunol. 2009;182:2305-2312.
107. Park SM, Ko HJ, Shim DH, et al. MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen. J Immunol. 2008;181:6447-6455.
108. Scanga CA, Bafica A, Feng CG, et al. MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infect Immun. 2004;72:2400-2404.
109. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411:599-603.
110. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606.
111. Hasegawa M, Yamazaki T, Kamada N, et al. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J Immunol. 2011;186:4872-4880.
112. Kim YG, Shaw MH, Warner N, et al. Cutting edge: Crohn's diseaseassociated Nod2 mutation limits production of proinflammatory cytokines to protect the host from Enterococcus faecalis-induced lethality. J Immunol. 2011;187:2849-2852.
113. Mantovani A, Cassatella MA, Costantini C, et al. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11:519-531.
114. Ribeiro CM, Hermsen T, Taverne-Thiele AJ, et al. Evolution of recognition of ligands from Gram-positive bacteria: similarities and differences in the TLR2-mediated response between mammalian vertebrates and teleost fish. J Immunol. 2010;184:2355-2368.
115. Thakur PC, Davison JM, Stuckenholz C, et al. Dysregulated phosphatidylinositol signaling promotes endoplasmic reticulum stress-mediated intestinal mucosal injury and inflammation in zebrafish. Dis Model Mech. 2013;86:1133-1149.
116. Adolph TE, Tomczak MF, Niederreiter L, et al. Paneth cells as a site of origin for intestinal inflammation. Nature. 2013;503:272-276.
117. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell. 2008;134:743-756.
118. Cahill CM, Rogers JT, Walker WA. The role of phosphoinositide 3-kinase signaling in intestinal inflammation. J Signal Transduct. 2012;2012:358476.
119. Prescott D, Atkinson B, Doring A, et al. Loss of phosphoinositide 3-kinase P110gamma is protective in the acute phase but detrimental in the resolution phase of hapten-induced colitis. In flamm Bowel Dis. 2013;19: 489-500.
120. Uno JK, Rao KN, Matsuoka K, et al. Altered macrophage function contributes to colitis in mice defective in the phosphoinositide-3 kinase subunit p110delta. Gastroenterology. 2010;139:1642-1653, 1653 e1641-e1646.
121. Niu X, Gao C, Jan Lo L, et al. Sec13 safeguards the integrity of the endoplasmic reticulum and organogenesis of the digestive system in zebrafish. Dev Biol. 2012;367:197-207.
122. Fleming A, Rubinsztein DC. Zebrafish as a model to understand autophagy and its role in neurological disease. Biochim Biophys Acta. 2011; 1812:520-526.
123. Holt A, Mitra S, van der Sar AM, et al. Discovery of zebrafish (Danio rerio) interleukin-23 alpha (IL-23alpha) chain, a subunit important for the formation of IL-23, a cytokine involved in the development of Th17 cells and inflammation. Mol Immunol. 2011;48:981-991.
124. Hundorfean G, Neurath MF, Mudter J. Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. In flamm Bowel Dis. 2012;18:180-186.
125. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-274.
126. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361: 2033-2045.
127. Moran CJ, Walters TD, Guo CH, et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. In flamm Bowel Dis. 2013;19:115-123.
128. Grayfer L, Belosevic M. Identification and molecular characterization of the interleukin-10 receptor 1 of the zebrafish (Danio rerio) and the goldfish (Carassius auratus L.). Dev Comp Immunol. 2012;36:408-417.
129. Zhang DC, Shao YQ, Huang YQ, et al. Cloning, characterization and expression analysis of interleukin-10 from the zebrafish (Danio rerion). J Biochem Mol Biol. 2005;38:571-576.
130. Kettleborough RN, Busch-Nentwich EM, Harvey SA, et al. A systematic genome-wide analysis of zebrafish protein-coding gene function. Nature. 2013;496:494-497.
131. Brand S, Beigel F, Olszak T, et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol. 2006;290:G827-G838.
132. Mizoguchi A. Healing of intestinal inflammation by IL-22. In flamm Bowel Dis. 2012;18:1777-1784.
133. Costa MM, Saraceni PR, Forn-Cuni G, et al. IL-22 is a key player in the regulation of inflammation in fish and involves innate immune cells and PI3K signaling. Dev Comp Immunol. 2013;41:746-755.
134. Toh MC, Goodyear M, Daigneault M, et al. Colonizing the embryonic zebrafish gut with anaerobic bacteria derived from the human gastrointestinal tract. Zebrafish. 2013;10:194-198.